"Proteinuria" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The presence of proteins in the urine, an indicator of KIDNEY DISEASES.
| Descriptor ID |
D011507
|
| MeSH Number(s) |
C12.777.934.734 C13.351.968.934.734 C23.888.942.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Proteinuria".
Below are MeSH descriptors whose meaning is more specific than "Proteinuria".
This graph shows the total number of publications written about "Proteinuria" by people in this website by year, and whether "Proteinuria" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 3 | 3 |
| 1997 | 1 | 2 | 3 |
| 1999 | 1 | 1 | 2 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 3 | 3 | 6 |
| 2004 | 1 | 1 | 2 |
| 2005 | 2 | 5 | 7 |
| 2006 | 2 | 2 | 4 |
| 2007 | 0 | 1 | 1 |
| 2008 | 2 | 5 | 7 |
| 2009 | 1 | 3 | 4 |
| 2010 | 1 | 2 | 3 |
| 2011 | 3 | 4 | 7 |
| 2012 | 0 | 5 | 5 |
| 2013 | 0 | 1 | 1 |
| 2014 | 2 | 1 | 3 |
| 2015 | 1 | 1 | 2 |
| 2016 | 3 | 2 | 5 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 2 | 3 |
| 2020 | 1 | 2 | 3 |
| 2021 | 1 | 3 | 4 |
| 2022 | 1 | 5 | 6 |
| 2023 | 1 | 1 | 2 |
| 2024 | 2 | 4 | 6 |
| 2025 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proteinuria" by people in Profiles.
-
Population pharmacokinetic analysis of bevacizumab in Japanese cancer patients with proteinuria: a prospective cohort study. Cancer Chemother Pharmacol. 2025 Mar 21; 95(1):46.
-
Long-term kidney outcomes in survivors of Wilms tumor: a single-center retrospective cohort study. Pediatr Nephrol. 2025 May; 40(5):1603-1611.
-
Construction and validation of a risk model of proteinuria in patients with omicron COVID-19: retrospective cohort study. Ren Fail. 2024 Dec; 46(2):2365979.
-
Development of clinical and laboratory biomarkers in an international cohort of 428 children with lupus nephritis. Pediatr Nephrol. 2024 Oct; 39(10):2959-2968.
-
Specific Gravity Improves Identification of Clinically Significant Quantitative Proteinuria from the Dipstick Urinalysis. Kidney360. 2024 Jun 01; 5(6):851-859.
-
Investigating the use of finerenone in children with chronic kidney disease and proteinuria: design of the FIONA and open-label extension studies. Trials. 2024 Mar 21; 25(1):203.
-
Low serum concentrations of bevacizumab and nivolumab owing to excessive urinary loss in patients with proteinuria: a case series. Cancer Chemother Pharmacol. 2024 Oct; 94(4):615-622.
-
Autoimmune and neuropsychiatric phenotypes in a Mecp2 transgenic mouse model on C57BL/6 background. Front Immunol. 2024; 15:1370254.
-
Proteinuria frequency and subsequent renal dysfunction in bevacizumab-treated patients: a single center, retrospective, observational study. Int J Clin Oncol. 2024 Apr; 29(4):398-406.
-
Proliferative glomerulonephritis with monoclonal IgG deposits: a unique case with a clinical course of over 46?years. BMC Nephrol. 2023 04 25; 24(1):109.